Literature DB >> 19584431

Stress-induced tau phosphorylation: functional neuroplasticity or neuronal vulnerability?

Robert A Rissman1.   

Abstract

Abnormally phosphorylated tau protein is a key component of the pathology seen in neurodegenerative tauopathies, such as Alzheimer's disease (AD). Despite its association with disease, tau phosphorylation (tau-P) also plays an important role in neuroplasticity, such as dendritic/synaptic remodeling seen in the hippocampus in response to environmental challenges, such as stress. To define the boundaries between neuroplasticity and neuropathology, studies have attempted to characterize the paradigms, stimuli, and signaling intermediates involved in stress-induced tau-P. Supporting an involvement of stress in AD are data demonstrating alterations in stress pathways and peptides in the AD brain and epidemiological data implicating stress exposure as a risk factor for AD. In this review, the question of whether stress-induced tau-P can be used as a model for examining the relationship between functional neuroplasticity and neuronal vulnerability will be discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584431      PMCID: PMC2906152          DOI: 10.3233/JAD-2009-1153

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  51 in total

1.  Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.

Authors:  E Planel; K Yasutake; S C Fujita; K Ishiguro
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

Review 2.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

Authors:  R M Sapolsky; L C Krey; B S McEwen
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

3.  Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.

Authors:  E B De Souza; P J Whitehouse; M J Kuhar; D L Price; W W Vale
Journal:  Nature       Date:  1986 Feb 13-19       Impact factor: 49.962

4.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.

Authors:  K Van Pett; V Viau; J C Bittencourt; R K Chan; H Y Li; C Arias; G S Prins; M Perrin; W Vale; P E Sawchenko
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

5.  Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

Authors:  C L Weaver; M Espinoza; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  2000 Sep-Oct       Impact factor: 4.673

6.  Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition.

Authors:  K Iqbal; T Zaidi; C H Thompson; P A Merz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

7.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Paired helical filaments associated with Alzheimer disease are readily soluble structures.

Authors:  R Rubenstein; R J Kascsak; P A Merz; H M Wisniewski; R I Carp; K Iqbal
Journal:  Brain Res       Date:  1986-04-30       Impact factor: 3.252

9.  Interaction of tau protein with the dynactin complex.

Authors:  Enrico Magnani; Juan Fan; Laura Gasparini; Matthew Golding; Meredith Williams; Giampietro Schiavo; Michel Goedert; Linda A Amos; Maria Grazia Spillantini
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

10.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

Authors:  E Braak; H Braak; E M Mandelkow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  21 in total

1.  Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor.

Authors:  Shannon N Campbell; Cheng Zhang; Louise Monte; Allyson D Roe; Kenner C Rice; Yvette Taché; Eliezer Masliah; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Human tau may modify glucocorticoids-mediated regulation of cAMP-dependent kinase and phosphorylated cAMP response element binding protein.

Authors:  Yudong Liu; Ying Su; Shenggang Sun; Tao Wang; Xian Qiao; Hui Li; Xiaoqin Run; Zhihou Liang
Journal:  Neurochem Res       Date:  2012-05       Impact factor: 3.996

3.  Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation.

Authors:  Robert A Rissman; Michael A Staup; Allyson Roe Lee; Nicholas J Justice; Kenner C Rice; Wylie Vale; Paul E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

4.  Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers.

Authors:  A Briones; S Gagno; E Martisova; M Dobarro; B Aisa; M Solas; R Tordera; Mj Ramírez
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Lipopolysaccharide-induced tau phosphorylation and kinase activity--modulation, but not mediation, by corticotropin-releasing factor receptors.

Authors:  Allyson D Roe; Michael A Staup; Jordi Serrats; Paul E Sawchenko; Robert A Rissman
Journal:  Eur J Neurosci       Date:  2011-07-04       Impact factor: 3.386

6.  Tau protein phosphorylation in diverse brain areas of normal and CRH deficient mice: up-regulation by stress.

Authors:  Peter Filipcik; Petr Novak; Boris Mravec; Katarina Ondicova; Gabriela Krajciova; Michal Novak; Richard Kvetnansky
Journal:  Cell Mol Neurobiol       Date:  2012-01-06       Impact factor: 5.046

7.  Stress, exercise, and Alzheimer's disease: a neurovascular pathway.

Authors:  Daniel A Nation; Suzi Hong; Amy J Jak; Lisa Delano-Wood; Paul J Mills; Mark W Bondi; Joel E Dimsdale
Journal:  Med Hypotheses       Date:  2011-03-12       Impact factor: 1.538

8.  Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer's disease progression.

Authors:  Fardin Nabizadeh; Mahsa Pourhamzeh; Saghar Khani; Ayda Rezaei; Fatemeh Ranjbaran; Niloofar Deravi
Journal:  Metab Brain Dis       Date:  2022-01-11       Impact factor: 3.584

9.  Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro.

Authors:  Robert A Whittington; László Virág; Maud Gratuze; Franck R Petry; Anastasia Noël; Isabelle Poitras; Geoffrey Truchetti; François Marcouiller; Marie-Amélie Papon; Noura El Khoury; Kevin Wong; Alexis Bretteville; Françoise Morin; Emmanuel Planel
Journal:  Neurobiol Aging       Date:  2015-05-09       Impact factor: 4.673

Review 10.  Trauma exposure and sleep: using a rodent model to understand sleep function in PTSD.

Authors:  William M Vanderheyden; Gina R Poe; Israel Liberzon
Journal:  Exp Brain Res       Date:  2014-03-13       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.